Zarrinpanah, T., et al. Next-generation vaccine adjuvants: Integrating nanotechnology, systems immunology, and computational approaches for precision vaccinology. Hum Vaccin Immunother, 2026 Dec, 22(1):2684345. PMID: 42405958
This paper offers a comprehensive overview of next-generation vaccine adjuvants, with particular emphasis on nanotechnology, systems immunology, and computational approaches. The review systematically connects the immunological mechanisms of adjuvants with their physicochemical properties, delivery platforms, and clinical applications, illustrating how advances in nanotechnology and systems biology can optimize their efficacy and safety.
The background of the paper reflects an ongoing shift from empirical adjuvant use to rational, mechanism-based immunoengineering, making it highly relevant for researchers aiming to design more effective and targeted vaccines. Importantly, this work underscores the transformative potential of integrating computational and nanotechnological strategies to revolutionize saponin-based adjuvant development, thus contributing significantly to the future of precise and potent immunizations.
Comment from DKI: While the paper covers a broad range of adjuvant types, saponins are featured prominently in sections discussing nanoparticulate immunostimulants and are considered key players in next-generation vaccine adjuvant strategies positioning QS-21 and Matrix-M as key examples of innovative immunostimulatory adjuvants. It highlights their capacity to induce strong cellular immunity, especially cytotoxic T lymphocyte responses, which are crucial for combating viruses and cancers.
Click here to access the full scientific paper.
